106 results on '"Lee, Ying-Hsiang"'
Search Results
2. Author Correction: Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
3. Real-World Experience of Angiotensin Receptor–Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease
4. The autonomic balance of heart rhythm complexity after renal artery denervation: insight from entropy of entropy and average entropy analysis
5. Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation
6. Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction
7. Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation
8. Closed loop stimulation helps with weaning from chronotropic incompetence-related ventilator dependence
9. Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF study
10. Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium
11. Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
12. Reduced-Dose Rivaroxaban Is Associated with Lower All-Cause Mortality in Older Patients with Nonvalvular Atrial Fibrillation.
13. Ventricular premature contraction associated with mitral valve prolapse
14. Frequency, Origin, and Outcome of Ventricular Premature Complexes in Patients With or Without Heart Diseases
15. Predictors and Outcomes of “Super-response” to Cardiac Resynchronization Therapy
16. Optimal Heart Rate Control Improves Long-Term Prognosis of Decompensated Heart Failure with Reduced Ejection Fraction.
17. Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy.
18. The Autonomic Imbalance of Myocardial Ischemia during Exercise Stress Testing: Insight from Short-Term Heart Rate Variability Analysis.
19. Safety and Efficacy of Submuscular Implantation With Resterilized Cardiac Implantable Electronic Device in Patients With Device Infection: A Retrospective Observational Study in Taiwan.
20. Silent and Huge Left Ventricular Pseudoaneurysm with Left Atrial Compression: Dedicated Spatial Resolution and Geometry by 3-Dimensional Echocardiography
21. Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan.
22. Combined Vasodepressive and Cardioinhibitory Syncope in a Patient with Hypertrophic Cardiomyopathy
23. Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction.
24. Exploratory Evaluation of Rhythm Control by Dronedarone in Combination With Low-Dose Rivaroxaban, Warfarin, Antiplatelet, or None of the Antithrombotic Therapy in High-Risk Patients With Non-Permanent Atrial Fibrillation: A Retrospective Cohort Study.
25. Effects of lorcaserin on cardiometabolic risk factors in overweight and obese patients: A systematic review and meta‐analysis.
26. Relations between baseline burden, maximum duration, and relative reduction of atrial fibrillation: Insights from continuous monitoring in rhythm control.
27. Effects of atrioventricular conduction delay on the outcome of cardiac resynchronization therapy.
28. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions: A single-center retrospective study.
29. B-Type Natriuretic Peptide Predicts the Outcome of Cardiac Resynchronization Therapy
30. TCTAP C-179 Renal Angioplasty Assisted Renal Denervation: Hybrid Strategy in a Patient with Resistant Hypertension and Renal Artery Stenosis.
31. FIRST-DEGREE ATRIOVENTRICULAR BLOCK IS AN INDEPENDENT FACTOR FOR RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY
32. TCTAP A-047 Physician Preferences for Recommending Renal Denervation to Hypertensive Patients Is Influenced by Patients' Antihypertensive Medication Nonadherence Due to Medication Side Effects.
33. TCTAP A-079 True Effect of Catheter-based Renal Denervation Across a Broad Spectrum of Patients: A Systematic Review and Meta-analysis.
34. EFFECTIVENESS OF RENAL DENERVATION IN SECONDARY ALDOSTERONISM RELATED HYPERTENSION FROM TAIWAN MULTICENTER EXPERIENCE.
35. UNDERSTANDING THE PATIENT PREFERENCE FOR CATHETER-BASED HYPERTENSION THERAPY: A PILOT STUDY FOR PHYSICIAN AWARENESS OF PATIENTS' BEHAVIOR IN TAIWAN.
36. SUBTYPES OF PATIENT PREFERENCE FOR CATHETER-BASED HYPERTENSION THERAPY: A PILOT STUDY BASED ON TAIWAN CONSENSUS ON RENAL DENERVATION (RDNI2).
37. RIVAROXABAN IN COMBINATION WITH ANTIARRHYTHMIC DRUGS DOES NOT INCREASE THE BLEEDING RISKS IN PATIENTS WITH NON-PERMANENT ATRIAL FIBRILLATION.
38. TCTAP A-080 Effectiveness of Renal Denervation in Patients with Kidney-related Secondary Causes of Hypertension.
39. TCTAP A-175 Catheter-Based Renal Denervation Could Lower Blood Pressure As Early As One Month.
40. Iron deficiency in Taiwanese patients with heart failure and reduced ejection fraction.
41. The Removal, Excision, Sterilization, and Quarantine (RESQ) Method is a Feasible Alternative Treatment for Cardiac Implantable Electronic Device Infections.
42. Utility of PREDICT-HF score in high-risk Asian heart failure patients receiving sacubitril/valsartan.
43. 2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
44. Preprocedural features of patients under antihypertensive drugs may help identify responders to renal denervation: a hypothesis-generating study.
45. Different left ventricular remodelling patterns and clinical outcomes between non-ischaemic and ischaemic aetiologies in heart failure patients receiving sacubitril/valsartan treatment.
46. A Ping Pong Thrombus in the Left Atrium.
47. The association between ivabradine and adverse cardiovascular events in acute decompensated HFrEF patients.
48. The evolution of guideline-directed medical therapy among decompensated HFrEF patients in sacubitril/valsartan era: Medical expenses and clinical effectiveness.
49. Corrigendum to: Intraventricular Conduction Disturbances After Transcatheter Aortic Valve Implantation.
50. The Use and Clinical Outcomes of Single-Burr Rotational Atherectomy: The Experience of a Local Hospital in Taiwan.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.